Press-release for stocks for nvsef

symbols : Nvsef

save search

Chemotherapy-induced Nausea and Vomiting Drugs Market Size to Grow by USD 759.79 million | Growing Cancer Population Driving the Market Growth | Technavio
Published: 2022-07-01 (Crawled : 12:00) - prnewswire.com
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| -0.06% | O: -1.35% H: 1.32% C: 1.31%
GSK | News | $43.75 0.51% -0.09% |

Health Technology

| 1.2% | O: -0.67% H: 1.93% C: 1.89%
GLAXF | News | $21.605 |

Health Technology

| -2.34% | O: 1.74% H: 0.0% C: -4.0%
growing cancer growth market

New Phase III data show Novartis tislelizumab significantly extended median overall survival by more than 6 months in first-line advanced esophageal cancer in combination with chemotherapy
Published: 2022-06-30 (Crawled : 09:00) - globenewswire.com
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| -0.55% | O: -0.5% H: 0.0% C: 0.0%
novartis cancer

Interstitial Cystitis Drugs Market Recorded 4.81% Y-O-Y Growth Rate in 2021| Evolving Opportunities with Perrigo Co. Plc & Pfizer Inc | Technavio
Published: 2022-06-29 (Crawled : 09:00) - prnewswire.com
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| -1.23% | O: -0.68% H: 0.0% C: 0.0%
ALPMY | $15.56 |

Manufacturing

| -5.08% | O: -5.08% H: 3.46% C: 2.81%
VTRS | News | $10.7 2.2% -0.29% |

Health Technology

| -3.56% | O: -1.49% H: 0.09% C: -1.19%
TEVJF | News | $7.6 |

Health Technology

| -8.87% | O: -9.17% H: 0.0% C: 0.0%
growth market

Herpes Treatment Market size to grow by USD 723.04 Mn | Market Research Insights highlight increasing prevalence of herpes infection as Key Driver | Technavio
Published: 2022-06-29 (Crawled : 04:00) - prnewswire.com
GSK | News | $43.75 0.51% -0.09% |

Health Technology

| 0.37% | O: -0.25% H: 1.08% C: 0.67%
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| -1.23% | O: -0.68% H: 0.0% C: 0.0%
GLAXF | News | $21.605 |

Health Technology

| -4.05% | O: -0.95% H: 1.01% C: -3.54%
BHC A | $8.53 2.03% 0.47% |

Health Technology

| -2.51% | O: 0.57% H: 0.57% C: -3.3%
TEVJF | News | $7.6 |

Health Technology

| -8.87% | O: -9.17% H: 0.0% C: 0.0%
VTRS | News | $10.7 2.2% -0.29% |

Health Technology

| -3.56% | O: -1.49% H: 0.09% C: -1.19%
treatment research infection market

Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published: 2022-06-27 (Crawled : 16:00) - prnewswire.com
AZNCF | News | $128.91 |

Health Technology

| 1.19% | O: -1.55% H: 4.43% C: 0.03%
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| 0.99% | O: 1.86% H: 1.05% C: 0.24%
LLY S | $324.71 0.15% 0.11% |

Health Technology

| 1.67% | O: 1.32% H: 0.0% C: 0.0%
GSK | News | $43.75 0.51% -0.09% |

Health Technology

| 0.14% | O: -0.16% H: 0.61% C: 0.18%
GLAXF | News | $21.605 |

Health Technology

| 0.0% | O: 0.47% H: 3.73% C: 3.73%
PFE A | $52.31 -0.23% -0.1% |

Health Technology

| 3.09% | O: 1.46% H: 1.45% C: 0.78%
SPPI | $0.7687 -1.45% -1.27% |

Health Technology

| -12.55% | O: 0.0% H: 2.28% C: -2.27%
SNYNF | News | $108.84 |

Health Technology

| 4.15% | O: 4.15% H: 0.0% C: 0.0%
BMY | News | $76.84 -0.21% -0.38% |

Health Technology

| -2.26% | O: 0.78% H: 1.72% C: 0.95%
SNY | News | $50.93 1.8% 1.26% |

Health Technology

| -2.71% | O: 0.53% H: 0.0% C: 0.0%
AZN | News | $65.95 -0.18% -0.09% |

Health Technology

| -0.83% | O: -0.36% H: 1.22% C: 0.38%
immunotherapy report therapy cancer market treatment

Cancer Gene Therapy Market to Grow at 10.1% through 2032, Amid High Adoption in Breast Cancer Treatment - Future Market Insights, Inc.
Published: 2022-06-27 (Crawled : 15:20) - prnewswire.com
CRNX | $18.855 1.1% 0.0% |

Health Technology

| -3.88% | O: 0.66% H: 1.22% C: -5.83%
AZN | News | $65.95 -0.18% -0.09% |

Health Technology

| -0.83% | O: -0.36% H: 1.22% C: 0.38%
ADAP A | $1.615 -5.0% 0.59% |

Health Technology

| 1.85% | O: 1.85% H: 6.67% C: 3.03%
AZNCF | News | $128.91 |

Health Technology

| 1.19% | O: -1.55% H: 4.43% C: 0.03%
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| 0.99% | O: 1.86% H: 1.05% C: 0.24%
GSK | News | $43.75 0.51% -0.09% |

Health Technology

| 0.14% | O: -0.16% H: 0.61% C: 0.18%
GLAXF | News | $21.605 |

Health Technology

| 0.0% | O: 0.47% H: 3.73% C: 3.73%
AMGN | $245.39 0.86% -0.93% |

Health Technology

| 0.07% | O: -0.08% H: 0.45% C: -0.13%
treatment therapy cancer market

Valued to be $104.2 Million by 2026, Eye Health Supplements Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 14:00) - prnewswire.com
PFE A | $52.31 -0.23% -0.1% |

Health Technology

| 3.09% | O: 1.46% H: 1.45% C: 0.78%
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| 0.99% | O: 1.86% H: 1.05% C: 0.24%
for health eye growth

Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
NVO | $111.64 0.19% -3.26% |

Health Technology

| -0.15% | O: 0.72% H: 0.0% C: 0.0%
CCXI A | $26.79 8.11% -3.39% |

Health Technology

| -3.32% | O: -4.88% H: 1.04% C: -1.25%
AZN | News | $65.95 -0.18% -0.09% |

Health Technology

| -0.83% | O: -0.36% H: 1.22% C: 0.38%
AZNCF | News | $128.91 |

Health Technology

| 1.19% | O: -1.55% H: 4.43% C: 0.03%
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| 0.99% | O: 1.86% H: 1.05% C: 0.24%
PFE A | $52.31 -0.23% -0.1% |

Health Technology

| 3.09% | O: 1.46% H: 1.45% C: 0.78%
JNJ | News | $179.52 1.13% -0.23% |

Health Technology

| -0.4% | O: 0.78% H: 0.94% C: 0.26%
disease for therapy growth

Irritable Bowel Syndrome Treatment Market to Surpass US$ 3,902.9 Million by 2030 - Coherent Market Insights
Published: 2022-06-24 (Crawled : 18:00) - prnewswire.com
ALPMY | $15.56 |

Manufacturing

| -3.77% | O: 4.33% H: 0.0% C: -2.44%
ALPMF | $16.71 |

Health Technology

| 6.07% | O: 0.99% H: 0.0% C: -0.5%
ABBV | $153.8 0.42% -0.09% |

Health Technology

| 3.64% | O: 1.57% H: 0.0% C: 0.0%
BHC A | $8.53 2.03% 0.47% |

Health Technology

| 17.33% | O: 5.78% H: 13.91% C: 13.78%
IRWD | $11.52 -0.09% 0.0% |

Health Technology

| 4.34% | O: 0.27% H: 2.08% C: 1.99%
TAK | News | $14.09 0.36% -1.7% |

Health Technology

| 1.42% | O: 0.36% H: 0.0% C: 0.0%
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| 3.4% | O: 2.38% H: 0.0% C: 0.0%
treatment market

Psoriasis Treatment Market Players Observe Rising Trend of Personalized Medicines, According to TMR Report
Published: 2022-06-24 (Crawled : 12:00) - prnewswire.com
AZN | News | $65.95 -0.18% -0.09% |

Health Technology

| 3.55% | O: 4.41% H: 0.0% C: 0.0%
JNJ | News | $179.52 1.13% -0.23% |

Health Technology

| 1.53% | O: 1.94% H: 0.0% C: 0.0%
PFE A | $52.31 -0.23% -0.1% |

Health Technology

| 6.15% | O: 2.96% H: 0.0% C: 0.0%
AZNCF | News | $128.91 |

Health Technology

| 3.2% | O: 0.64% H: 4.18% C: 1.33%
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| 3.4% | O: 2.38% H: 0.0% C: 0.0%
LLY S | $324.71 0.15% 0.11% |

Health Technology

| 5.04% | O: 3.32% H: 0.0% C: 0.0%
treatment report psoriasis market

Novartis receives positive CHMP opinion for Scemblix®, a novel treatment for adult patients with chronic myeloid leukemia
Published: 2022-06-24 (Crawled : 12:00) - globenewswire.com
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| 3.4% | O: 2.38% H: 0.0% C: 0.0%
scemblix treatment for chmp novartis leukemia positive

Rheumatoid Arthritis Drugs Market Size to Grow by USD 14.90 Billion | 37% of the growth will originate from Europe | Technavio
Published: 2022-06-24 (Crawled : 09:00) - prnewswire.com
ALPMY | $15.56 |

Manufacturing

| -3.77% | O: 4.33% H: 0.0% C: -2.44%
SNY | News | $50.93 1.8% 1.26% |

Health Technology

| 0.69% | O: 3.49% H: 0.0% C: 0.0%
ALPMF | $16.71 |

Health Technology

| 6.07% | O: 0.99% H: 0.0% C: -0.5%
ABBV | $153.8 0.42% -0.09% |

Health Technology

| 3.64% | O: 1.57% H: 0.0% C: 0.0%
GLAXF | News | $21.605 |

Health Technology

| 1.32% | O: 3.19% H: 2.28% C: -1.81%
AMGN | $245.39 0.86% -0.93% |

Health Technology

| 1.56% | O: 0.92% H: 0.82% C: 0.56%
GSK | News | $43.75 0.51% -0.09% |

Health Technology

| 2.87% | O: 1.79% H: 0.95% C: 0.92%
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| 3.4% | O: 2.38% H: 0.0% C: 0.0%
GLMD | $0.593 -8.77% -4.61% |

Health Technology

| 24.53% | O: 1.21% H: 0.0% C: -3.5%
europe growth market

Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments
Published: 2022-06-23 (Crawled : 01:00) - globenewswire.com
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| 3.71% | O: 0.3% H: 0.0% C: 0.0%
research disease novartis

Novartis Tafinlar + Mekinist receives FDA approval for first tumor-agnostic indication for BRAF V600E solid tumors
Published: 2022-06-22 (Crawled : 00:00) - globenewswire.com
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| 3.71% | O: 0.3% H: 0.0% C: 0.0%
fda for novartis approval tafinlar

Global Recombinant Vaccines Market to Surpass US$ 1,809.7 Million by 2030 - Coherent Market Insights
Published: 2022-06-22 (Crawled : 18:00) - prnewswire.com
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| 2.08% | O: -1.57% H: 0.0% C: 0.0%
JNJ | News | $179.52 1.13% -0.23% |

Health Technology

| 5.76% | O: 1.36% H: 0.0% C: 0.0%
SNY | News | $50.93 1.8% 1.26% |

Health Technology

| 2.14% | O: -0.4% H: 0.0% C: 0.0%
market

Novartis expands Beacon of Hope through alliances with Historically Black Medical Schools to address systemic health disparities
Published: 2022-06-22 (Crawled : 12:00) - prnewswire.com
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| 2.08% | O: -1.57% H: 0.0% C: 0.0%
SNY | News | $50.93 1.8% 1.26% |

Health Technology

| 2.14% | O: -0.4% H: 0.0% C: 0.0%
beacon novartis health

Novartis plans to petition the U.S. Court of Appeals for the Federal Circuit for further review to uphold validity of the Gilenya® (fingolimod) dosing regimen patent
Published: 2022-06-21 (Crawled : 20:00) - globenewswire.com
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| 2.08% | O: -1.57% H: 0.0% C: 0.0%
gilenya patent for novartis review

Liver Cancer Drugs Market size to grow by USD 5.29 billion | Market Research Insights highlight the increasing incidence of liver cancer as Key Driver | Technavio
Published: 2022-06-21 (Crawled : 03:00) - prnewswire.com
AZN | News | $65.95 -0.18% -0.09% |

Health Technology

| 7.74% | O: 2.03% H: 0.0% C: 0.0%
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| 3.52% | O: 1.41% H: 0.0% C: 0.0%
research liver cancer market

Global Meningitis Vaccines Market to Surpass US$ 6,669.3 Million by 2030 - Coherent Market Insights
Published: 2022-06-20 (Crawled : 19:00) - prnewswire.com
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| 3.52% | O: 1.41% H: 0.0% C: 0.0%
SNY | News | $50.93 1.8% 1.26% |

Health Technology

| 3.57% | O: 1.4% H: 0.0% C: 0.0%
market

Global Gene Therapy Market Research Report 2022-2031 Featuring Major Players - Novartis AG; Bluebird bio, Inc.; Spark Therapeutics, Inc; Audentes Therapeutics; Voyager Therapeutics
Published: 2022-06-20 (Crawled : 12:00) - prnewswire.com
SNY | News | $50.93 1.8% 1.26% |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $108.84 |

Health Technology

| Email alert Add to watchlist
QURE | $19.14 2.68% 0.0% |

Health Technology

| Email alert Add to watchlist
CLLS | $2.68 -5.3% 0.0% |

Health Technology

| Email alert Add to watchlist
SRPT | $75.7 0.99% 0.0% |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $84.85 |

Health Technology

| Email alert Add to watchlist
AGTC | $0.7825 1.62% -2.53% |

Health Technology

| Email alert Add to watchlist
BLUE | $4.27 3.14% -0.48% |

Health Technology

| Email alert Add to watchlist
NVS | News | $84.36 -0.2% 0.33% |

Health Technology

| Email alert Add to watchlist
research report novartis therapeutics therapy market

← Previous
1
2
3
4
5
6
7
8
9
…
14
15
Next →

symbols : Nvsef

save search

Your saved searches

Mentioned Today

symbols : Nvsef save search

Your saved searches

Mentioned Today

symbols : Nvsef

save search